Ex-pharmaceutical CEO Martin Shkreli faces more charges

Allen Cone NEW YORK, May 3 (UPI) -- Martin Shkreli, the former pharmaceutical CEO who hiked the price of a life-saving drug, likely is facing additional charges in a case with his other company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.